3 Result: Sanofi
Acuity Brands Posts Mixed Results; Sanofi, Teva Ink Anti-TL1A Therapy Deal
October 04th, 2023
Acuity Brands, Inc. (NYSE: AYI) posted fourth-quarter fiscal 2023 earnings of $3.97 per share, surpassing the consensus EPS estimate of $3.72. Quarterly sales for the company totaled $1.01 billion, slightly below analysts' revenue projections of $1.0. Read more
Breaking: Sanofi's Legal Win, Innovative Eyewear's License Deal
June 20th, 2023
Shares of Sanofi (Nasdaq: SNY) surged in pre-market trading following the announcement of a favorable outcome in an International Chamber of Commerce dispute. The tribunal ruled in favor of Sanofi, dismissing Boehringer Ingelheim's. Read more
Innate Pharma, Sanofi: FDA Grants FTD to SAR'579/IPH6101; Hyzon Motors Posts Q1 Loss - IPHA, HYZN News
June 08th, 2023
Innate Pharma (Nasdaq: IPHA) shared important news from Sanofi (Nasdaq: SNY) regarding the U.S. Food and Drug Administration (FDA) granting Fast Track Designation for SAR'579 / IPH6101 to treat hematological malignancies. The FDA's Fast Trac. Read more
Want To Find Some News?
News By Industries
Recent Post
-
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025Earnings Preview: Credo Technology, MongoDB, and Hafnia in Focus
November 30th, 2025
Member Login